Skip to main content
Erschienen in: Rheumatology International 3/2014

01.03.2014 | Original Article

Is magnetotherapy applied to bilateral hips effective in Ankylosing spondylitis patients? A randomized, double-blind, controlled study

verfasst von: Yasemin Turan, Kevser Bayraktar, Fatih Kahvecioglu, Engin Tastaban, Elif Aydin, Imran Kurt Omurlu, Isil Karatas Berkit

Erschienen in: Rheumatology International | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

This double-blind, randomized controlled study was conducted with the aim to investigate the effect of magnetic field therapy applied to the hip region on clinical and functional status in ankylosing spondylitis (AS) patients. Patients with AS (n = 66) who were diagnosed according to modified New York criteria were enrolled in this study. Patients were randomly divided in two groups. Participants were randomly assigned to receive magnetic field therapy (2 Hz) (n = 35), or placebo magnetic field therapy (n = 31) each hip region for 20 min. Patients in each group were given heat pack and short-wave treatments applied to bilateral hip regions. Both groups had articular range of motion and stretching exercises and strengthening exercises for surrounding muscles for the hip region as well as breathing and postural exercises by the same physical therapist. These treatment protocols were continued for a total of 15 sessions (1 session per day), and patients were examined by the same physician at months 1, 3 and 6. Visual analogue scale (VAS) pain, VAS fatigue, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrologic Index (BASMI), DFI, Harris hip assessment index and Ankylosing Spondylitis Quality of Life scale (ASQOL) were obtained at the beginning of therapy and at month 1, month 3 and month 6 for each patient. There were no significant differences between groups in the VAS pain, VAS fatigue, morning stiffness, BASDAI, BASFI, BASMI, DFI, Harris hip assessment index and ASQoL at baseline, month 1, month 3 or month 6 (p > 0.05). Further randomized, double-blind controlled studies are needed in order to establish the evidence level for the efficacy of modalities with known analgesic and anti-inflammatory action such as magnetotherapy, particularly in rheumatic disorders associated with chronic pain.
Literatur
1.
Zurück zum Zitat Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61(Suppl3):iii8–iii18PubMed Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61(Suppl3):iii8–iii18PubMed
2.
Zurück zum Zitat Bodur H, Sivas F, Yilmaz O, Ozgocmen S, Gunaydin R, Kaya T et al (2011) Turkish league against rheumatism national recommendations for the management of ankylosing spondylitis. Turk J Rheumatol 26:173–186CrossRef Bodur H, Sivas F, Yilmaz O, Ozgocmen S, Gunaydin R, Kaya T et al (2011) Turkish league against rheumatism national recommendations for the management of ankylosing spondylitis. Turk J Rheumatol 26:173–186CrossRef
3.
Zurück zum Zitat Gran JT, Husby G (1998) Ankylosing spondylitis: prevalence and demography. In: Klippel JH, Dieppe PA (eds) Rheumatology, vol 6. Mosby, St Louis, pp 15.1–15.6 Gran JT, Husby G (1998) Ankylosing spondylitis: prevalence and demography. In: Klippel JH, Dieppe PA (eds) Rheumatology, vol 6. Mosby, St Louis, pp 15.1–15.6
4.
Zurück zum Zitat Khan MA (1994) Ankylosing spondylitis: clinical features. In: Klippel JH, Dieppe PA (eds) Rheumatology, vol 3. Mosby, St Louis, pp 25.1–25.10 Khan MA (1994) Ankylosing spondylitis: clinical features. In: Klippel JH, Dieppe PA (eds) Rheumatology, vol 3. Mosby, St Louis, pp 25.1–25.10
5.
Zurück zum Zitat Ibn Yacoub Y, Amine B, Laatiris A, Hajjaj-Hassouni N (2012) Gender and disease features in Moroccan patients with ankylosing spondylitis. Clin Rheumatol 31(2):293–297PubMedCrossRef Ibn Yacoub Y, Amine B, Laatiris A, Hajjaj-Hassouni N (2012) Gender and disease features in Moroccan patients with ankylosing spondylitis. Clin Rheumatol 31(2):293–297PubMedCrossRef
6.
Zurück zum Zitat Calin A, Elswood J (1988) The relationship between pelvic, spinal and hip involvement in ankylosing spondylitis: one disease process or several? Br J Rheumatol 27:393–395PubMedCrossRef Calin A, Elswood J (1988) The relationship between pelvic, spinal and hip involvement in ankylosing spondylitis: one disease process or several? Br J Rheumatol 27:393–395PubMedCrossRef
7.
Zurück zum Zitat Kobelt G, Andlin-Sobocki P, Maksymowych WP (2006) Costs and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 33:289–295PubMed Kobelt G, Andlin-Sobocki P, Maksymowych WP (2006) Costs and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 33:289–295PubMed
8.
Zurück zum Zitat Vander Cruyssen B, Vastesaeger N, Collantes-Estévez E (2013) Hip disease in ankylosing spondylitis. Curr Opin Rheumatol 25(4):448–454PubMedCrossRef Vander Cruyssen B, Vastesaeger N, Collantes-Estévez E (2013) Hip disease in ankylosing spondylitis. Curr Opin Rheumatol 25(4):448–454PubMedCrossRef
9.
Zurück zum Zitat Guan M, Wang J, Zhao L, Xiao J, Li Z, Shi Z (2013) Management of hip involvement in ankylosing spondylitis. Clin Rheumatol 32(8):1115–1120PubMedCrossRef Guan M, Wang J, Zhao L, Xiao J, Li Z, Shi Z (2013) Management of hip involvement in ankylosing spondylitis. Clin Rheumatol 32(8):1115–1120PubMedCrossRef
10.
Zurück zum Zitat Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 23(1):CD002822 Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 23(1):CD002822
11.
Zurück zum Zitat Gmitrov J, Ohkubo C, Okano H (2002) Effect of 0.25 T static magnetic fields on microcirculation in rabbits. Bioelectromagnetics 23(3):224–229PubMedCrossRef Gmitrov J, Ohkubo C, Okano H (2002) Effect of 0.25 T static magnetic fields on microcirculation in rabbits. Bioelectromagnetics 23(3):224–229PubMedCrossRef
12.
Zurück zum Zitat Weinberger A, Nyska A, Giler S (1996) Treatment of experimental inflammatory synovitis with continuous magnetic field. Isr J Med Sci 32(12):1197–1201PubMed Weinberger A, Nyska A, Giler S (1996) Treatment of experimental inflammatory synovitis with continuous magnetic field. Isr J Med Sci 32(12):1197–1201PubMed
13.
14.
Zurück zum Zitat van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368PubMedCrossRef van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368PubMedCrossRef
15.
Zurück zum Zitat Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21(9):1694–1698PubMed Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21(9):1694–1698PubMed
16.
Zurück zum Zitat Garrett SL, Jenkinson TR, Kennedy LG, Whitelock HC, Gaisford P, Calin A (1994) A new approach to deWning disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291PubMed Garrett SL, Jenkinson TR, Kennedy LG, Whitelock HC, Gaisford P, Calin A (1994) A new approach to deWning disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291PubMed
17.
Zurück zum Zitat Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285PubMed Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285PubMed
18.
Zurück zum Zitat Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the bath ankylosing spondylitis disease activity index: reliability and validity. Rheumatol Int 25(4):280–284PubMedCrossRef Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the bath ankylosing spondylitis disease activity index: reliability and validity. Rheumatol Int 25(4):280–284PubMedCrossRef
19.
Zurück zum Zitat Ozer HT, Sarpel T, Gulek B, Alparslan ZN, Erken E (2005) The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity. Clin Rheumatol 24(2):123–128PubMedCrossRef Ozer HT, Sarpel T, Gulek B, Alparslan ZN, Erken E (2005) The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity. Clin Rheumatol 24(2):123–128PubMedCrossRef
20.
Zurück zum Zitat MacKay K, Brophy S, Mack C, Doran M, Calin A (2000) The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol 27(12):2866–2872PubMed MacKay K, Brophy S, Mack C, Doran M, Calin A (2000) The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol 27(12):2866–2872PubMed
21.
Zurück zum Zitat Harris WH (1969) Traumatic arthritis of the hip after dislocation and acetabular fractures: treated by mould arthroplasty: an end-result study using a new method of result evaluation. J Bone Joint Surg Am 51-A:737 Harris WH (1969) Traumatic arthritis of the hip after dislocation and acetabular fractures: treated by mould arthroplasty: an end-result study using a new method of result evaluation. J Bone Joint Surg Am 51-A:737
22.
Zurück zum Zitat Doward LC, Spoorenberg A, Cook SA et al (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20–26PubMedCrossRef Doward LC, Spoorenberg A, Cook SA et al (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20–26PubMedCrossRef
23.
Zurück zum Zitat Duruöz MT, Doward L, Turan Y, Cerrahoglu L, Yurtkuran M, Calis M, et al. (2013) Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Rheumatol Int Jun 14 Duruöz MT, Doward L, Turan Y, Cerrahoglu L, Yurtkuran M, Calis M, et al. (2013) Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Rheumatol Int Jun 14
24.
Zurück zum Zitat Adey WR (2004) Potential therapeutic application of nonthermal electromagnetic fields: ensemble organization of cells in tissue as a factor in biological field sensing. In: Rosch PJ, Markov MS (eds) Bioelectromagnetic medicine. Marcel Dekker, New York, pp 1–12 Adey WR (2004) Potential therapeutic application of nonthermal electromagnetic fields: ensemble organization of cells in tissue as a factor in biological field sensing. In: Rosch PJ, Markov MS (eds) Bioelectromagnetic medicine. Marcel Dekker, New York, pp 1–12
25.
Zurück zum Zitat Shupak N (2003) Therapeutic uses of pulsed magnetic-field exposure: a review. Radio Sci Bull 307:9–32 Shupak N (2003) Therapeutic uses of pulsed magnetic-field exposure: a review. Radio Sci Bull 307:9–32
26.
Zurück zum Zitat Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70(6):896–904PubMedCentralPubMedCrossRef Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70(6):896–904PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Nienhuis RL, Hoekstra AJ (1984) Transcutaneous electronic nerve stimulation in ankylosing spondylitis. Arthritis Rheum 27(9):1074–1075PubMedCrossRef Nienhuis RL, Hoekstra AJ (1984) Transcutaneous electronic nerve stimulation in ankylosing spondylitis. Arthritis Rheum 27(9):1074–1075PubMedCrossRef
28.
Zurück zum Zitat Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 23(1):CD002822 Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 23(1):CD002822
29.
Zurück zum Zitat Cheing GLY, Hui Chan CWY (2002) Does four weeks of TENS and/or isometric exercise produce cumulative reduction of osteoarthritic knee pain? Clin Rehabil 16(7):749–760PubMedCrossRef Cheing GLY, Hui Chan CWY (2002) Does four weeks of TENS and/or isometric exercise produce cumulative reduction of osteoarthritic knee pain? Clin Rehabil 16(7):749–760PubMedCrossRef
Metadaten
Titel
Is magnetotherapy applied to bilateral hips effective in Ankylosing spondylitis patients? A randomized, double-blind, controlled study
verfasst von
Yasemin Turan
Kevser Bayraktar
Fatih Kahvecioglu
Engin Tastaban
Elif Aydin
Imran Kurt Omurlu
Isil Karatas Berkit
Publikationsdatum
01.03.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 3/2014
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2941-7

Weitere Artikel der Ausgabe 3/2014

Rheumatology International 3/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.